[O17] Oral Session 17　肝胆膵
【E】

[O17-1] A Phase II Trial of Nivolumab, Gemcitabine and S-1 as the First-Line Treatment in Patients with Biliary Tract Cancer

^○Ming-Huang Chen¹, Nai-Jung Chiang², Li-Yuan Bai³, Chien-Jui Huang⁴, San-Chi Chen¹, Chin-Fu Hsiao², Yan-Shen Shan⁴, Yung-Yeh Su², Li‐Tzong Chen² (1.Department of Oncology, Taipei Veterans General Hospital, 2.National Institute of Cancer Research, National Health Research Institutes, 3.China Medical University Hospital, 4.National Cheng Kung University)